Arrowstreet Capital, Limited Partnership Marker Therapeutics, Inc. Transaction History

Arrowstreet Capital, Limited Partnership

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$1.59 - $3.35 $193,741 - $408,197	-121,850 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.68 - $4.85 $139,896 - $253,169	52,200 Added 74.95%	121,850 $351,000
Q3 2019 Nov 14, 2019	BUY	$4.1 - $9.0 $2,050 - $4,500	500 Added 0.72%	69,650 $356,000
Q2 2019 Aug 14, 2019	BUY	$5.15 - $7.92 $98,751 - $151,866	19,175 Added 38.37%	69,150 $548,000
Q1 2019 May 15, 2019	BUY	$5.1 - $6.71 $254,872 - $335,332	49,975 New	49,975 $330,000

475K

Ticker MRKR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,599,200
Market Cap $163M
Description
Marker Therapeutics, Inc., a clinical-stage immuno-oncology company, engages in the development and commercialization of various T cell-based immunotherapies and peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications in the United States. Its MultiTAA-specific T cell technology is based on the manufact...

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.